AbbVie’s Q3 beat should keep ‘train rolling’ as company eyes bolt-on deals
AbbVie beat third quarter sales and earnings expectations and raised its full-year profit outlook Friday, powered by its immunology blockbusters…
AbbVie beat third quarter sales and earnings expectations and raised its full-year profit outlook Friday, powered by its immunology blockbusters…